首页> 外文期刊>Medicine. >MicroRNA expression profiling of lung adenocarcinoma in Xuanwei, China: A preliminary study
【24h】

MicroRNA expression profiling of lung adenocarcinoma in Xuanwei, China: A preliminary study

机译:玄威肺腺癌的MicroRNA表达剖析:初步研究

获取原文
           

摘要

MicroRNAs (miRNAs) have been proved to be related to the development and progression of lung cancer. However, the expression signatures of miRNAs in lung adenocarcinoma in Xuanwei are not yet clear. The current study aimed to identify the potential miRNA profiles in lung adenocarcinoma in Xuanwei by microarray. The miRNA profiles in 24 lung adenocarcinoma and paired non-tumor tissues in Xuanwei were ascertained by using the Exiqon miRCURY LNA microRNA Array (v.18.0). The results of the microarrays were further verified by quantitative real-time polymerase chain reaction (qRT-PCR) detection. Bioinformatics analysis was used to carry out the functional annotations of differentially expressed miRNAs. One hundred fifty five differentially expressed (≥2-fold change) miRNAs were identified (65 upregulated and 90 downregulated). QRT-PCR was used to validate the top 4 most upregulated and downregulated miRNAs, and the results were generally consisted with microarray. Furthermore, the differentially expressed miRNAs were significantly enriched in numerous common pathways that were bound up with cancer. The pathways included focal adhesion and signaling pathways, such as cyclic guanosine monophosphate -protein kinase G (cGMP-PKG) signaling pathways, mitogen-activated protein kinase (MAPK) signaling pathway, and Hippo signaling pathway, etc. Our study identified the potential miRNA profiles in lung adenocarcinoma in Xuanwei by microarray. These miRNAs might be used as biomarkers for diagnosis and/or prognosis for lung cancer in Xuanwei and therefore warrant further investigation. Further study is needed to reveal the potential role of these miRNAs in the carcinogenesis of XuanWei Lung Cancer (XWLC).
机译:Micrornas(MiRNA)已被证明与肺癌的开发和进展有关。然而,玄威肺腺癌中miRNA的表达签名尚不清楚。目前的研究旨在通过微阵列鉴定宣因肺腺癌中的潜在miRNA谱。通过使用exiqon mircury lna microRNA阵列确定了24例肺腺癌和Xuanwei配对非肿瘤组织中的miRNA型材(V.18.0)。通过定量实时聚合酶链反应(QRT-PCR)检测进一步验证微阵列的结果。生物信息学分析用于进行差异表达miRNA的功能性注释。鉴定了一百五十五个差异表达(≥2倍的变化)miRNA(65个上调和90个下调)。 QRT-PCR用于验证前4个最上调和下调的miRNA,结果通常与微阵列组成。此外,差异表达的miRNA在含有癌症的许多常见途径中显着富集。途径包括局部粘附和信号通路,例如环状鸟氨酸单磷酸胺 - 蛋白激酶G(CGMP-PKG)信号传导途径,丝裂原激活的蛋白激酶(MAPK)信号通路和河马信号通路等。我们的研究确定了潜在的miRNA微阵列Xuanwai肺腺癌的谱。这些miRNA可以用作宣因肺癌诊断和/或预后的生物标志物,因此需要进一步调查。需要进一步研究来揭示这些miRNA在宣因肺癌(XWLC)致癌中的潜在作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号